Expression of interleukin 1β and interleukin 1β converting enzyme by intestinal macrophages in health and inflammatory bowel disease

Gut

Volumn 42, Issue 2, 1998, Pages 214-219

  McAlindon, M E ^a   Hawkey, C J ^a   Mahida, Y R ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Crohn's disease; Interleukin 1 ; Interleukin 1 converting enzyme; Lipopolysaccharide; Macrophages; Ulcerative colitis

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOPATHOGENESIS; INFLAMMATORY INFILTRATE; MACROPHAGE ACTIVATION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS;

EID: 0031921472     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.2.214     Document Type: Article

References (38)

1. Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol 1989;44:153-205.
2. Di Giovine FS, Duff GW. Interleukin 1: the first interleukin. Immunol Today 1990;11:13-20.
3. Cerretti DP, Kozlosky CJ, Mosley B, et al. Molecular cloning of the interleukin-1β converting enzyme. Science 1992;256:97-100.
4. Thornberry NA, Bull HG, Calaycay JR, et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 1992;356: 768-74.
5. Wilson KP, Black J-AF, Thomson JA, et al. Structure and mechanism of interleukin-1β converting enzyme. Nature 1994;370:270-5.
6. Mahida YR, Lamming CED, Gallagher A, Hawthorne AB, Hawkey CJ. 5-Aminosalicylic acid is a potent inhibitor of interleukin-1β production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease. Gut 1991;32:50-4.
7. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of interleukin 1 in inflammatory bowel disease - enhanced production during active disease. Gut 1990;31:686 9.
8. Cappello M, Keshav S, Prince C, Jewell DP, Gordon S. Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut 1992;33: 1214-9.
9. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin-1β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 1989; 30:835-8.
10. Youngman KR, Simon PL, West GA, et al. Localisation of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 1993; 104:749-58.
11. Riley SA, Mani V, Goodman MJ, Herd ME, Dutt S, Turnberg LA. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse. Gut 1988;29: 669-74.
12. Mahida YR, Galvin A, Gray T, et al. Migration of human intestinal lamina propria lymphocytes, macrophages and eosinophils following the loss of surface epithelial cells. Clin Exp Immunol 1997;109:377-86.
13. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;277:680-4.
14. Hogquist KA, Unanue ER, Chaplin DD. Release of IL-1 from mononuclear phagocytes. J Immunol 1991;147:2181-6.
15. Simon GL, Gorbach SL. Normal alimentary tract microflora. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the gastrointestinal tract. New York: Raven Press, 1995:53-69.
16. Perregaux B, Gabel CA. Interleukin-Iβ maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J Biol Chem 1994;269:15195-203.
17. Kruis W, Schussler P, Weinzierl M, Galanos C, Eisenburg J. Circulating lipid A antibodies despite absence of systemic endotoxaemia in patients with Crohn's disease. Dig Dis Sci 1984;29:502-7.
18. Wellman W, Fink PC, Benner F, Scmidt FW. Endotoxaemia in active Crohn's disease: treatment with whole gut irrigation and 5-aminosalicylic acid. Gut 1986;27:814-20.
19. Gardiner KR, Halliday MI, Barclay GR, Milne L, Brown D, Stephens S, Maxwell RJ, Rowlands BJ. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 1995;36:897-901.
20. Mazlam MZ, Hodgson HJF. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut 1992;33:773-8.
21. McAlindon ME, Hawkey CJ, Mahida YR. Interleukin-1β converting enzyme (ICE) is expressed by macrophages in the lamina propria of active inflammatory bowel disease (IBD) mucosa (abstract). Gut 1996;39(suppl 3):A93.
22. Isaacs KL, Sartor RB, Haskill S. Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 1992;103:1587-95.
23. Selby WS, Poulter LW, Hobbs S, Jewell DP, Janossy G. Heterogeneity of HLA-DR positive histiocytes in human intestinal lamina propria: a combined histochemical and immunohistological analysis. J Clin Pathol 1983;36:379-84.
24. Mahida YR, Patel S, Gionchetti P, Vaux D, Jewell DP. Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut 1989;30:826-34.
25. Mahida YR, Patel S, Wu K, Jewell DP. Interleukin 2 receptor expression by macrophages in inflammatory bowel disease. Clin Exp Immunol 1988;74:382-6.
26. Grimm MC, Pullman WE, Bennett GM, Sullivan PJ, Pavli P, Doe WF. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J Gastroenterol Hepatol 1995;10:387-95.
27. + monocyte derived cells. Gut 1995;37:367-73.
28. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 1993;75:653-60.
29. Ping L, Allen H, Benerjee S, et al. Mice deficient in IL-1β-converting enzyme are defective in production of mature IL-1β and resistant to endotoxic shock. Cell 1995;80:401-11.
30. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
31. Nett-Fiordalisi M, Tomaselli K, Russell JH, Chaplin DD. Macrophage apoptosis in the absence of active interleukin-1β-converting enzyme. J Leukoc Biol 1995;58:717-24.
32. Jung HC, Eckmann L, Yang S-K, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995;95:55-65.
33. Reinecker H-C, Loh EY, Ringler DJ, Mehta A, Rombeau JL, MacDermott RP. Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 1995;108:40-50.
34. Mahida YR, Makh S, Hyde S, Gray T, Borriello SP. Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin-8 production and apoptosis following cell detachment. Gut 1996;38:337-47.
35. Mahida YR, Wu KC, Jewell DP. Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease. Gut 1989;30:1362-70.
36. Cominelli F, Nast CC, Clark BD, et al. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 1990;86:972-80.
37. Miller BE, Krasney PA, Gauvin DM, et al. Inhibition of mature IL-1β production in murine macrophages and a murine model of inflammation by WIN 67694, an inhibitor of IL-1β converting enzyme. J Immunol 1995;154:1331-8.
38. Ramage P, Cheneval D, Chvei M, et al. Expression, refolding, and autocatalytic proteolytic processing of the interleukin-1β-converting enzyme precursor. J Biol Chem 1995;270:9378-83.